BlackRock’s iSpecimen ISPC Stock Holding History

BlackRock’s Portfolio ISPC Stock Details ISPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$188	Hold	71	–	–	﹤0.01%	5595
2026 Q1	$444	Hold	71	–	–	﹤0.01%	5576
2025 Q4	$735	Hold	71	–	–	﹤0.01%	5432
2025 Q3	$3.65K	Hold	71	–	–	﹤0.01%	5290
2025 Q2	$2.77K	Hold	71	–	–	﹤0.01%	5307
2025 Q1	$3K	Hold	71	–	–	﹤0.01%	5285
2024 Q4	$7.51K	Hold	71	–	–	﹤0.01%	5194
2024 Q3	$13.3K	Hold	71	–	–	﹤0.01%	4975
2024 Q2	$17.5K	Hold	71	–	–	﹤0.01%	5022
2024 Q1	$13.1K	Hold	71	–	–	﹤0.01%	5062
2023 Q4	$28.4K	Hold	71	–	–	﹤0.01%	5041
2023 Q3	$35.2K	Hold	71	–	–	﹤0.01%	5066
2023 Q2	$81.1K	Hold	71	–	–	﹤0.01%	4982
2023 Q1	$76K	Hold	71	–	–	﹤0.01%	5035
2022 Q4	$78K	Hold	71	–	–	﹤0.01%	5117
2022 Q3	$94K	Hold	71	–	–	﹤0.01%	5193
2022 Q2	$124K	Sell	71 -18	-20%	-$44.1K	﹤0.01%	5172
2022 Q1	$382K	Buy	89 +80	+889%	+$313K	﹤0.01%	4948
2021 Q4	$56K	Buy	9 +1	+13%	+$7.18K	﹤0.01%	5383
2021 Q3	$35K	Buy	+8	New	+$38.8K	﹤0.01%	5332

Other funds holding ISPC

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

BlackRock's ISPC Position: Q2 2026 in Review

BlackRock held its iSpecimen (ISPC) position steady in Q2 2026 at 71 shares worth $188. The position accounts for ﹤0.01% of the portfolio, ranked #5595.

BlackRock first reported a position in ISPC in Q3 2021 and has held it in 20 quarters since. The position peaked at $382K in Q1 2022. 8 funds tracked by Wall St. Rank hold ISPC as of Q2 2026.

BlackRock held 71 shares of iSpecimen worth $188 as of Q2 2026.
BlackRock left its iSpecimen share count unchanged in Q2 2026.
iSpecimen made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5595 holding.
BlackRock first reported a position in iSpecimen in Q3 2021 and has held it in 20 quarters since.
BlackRock's iSpecimen position peaked at $382K in Q1 2022.
8 funds tracked by Wall St. Rank held iSpecimen as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.